Orna Therapeutics
Rahul Vungutur is a Senior Research Associate at Orna Therapeutics, where responsibilities include the functional optimization of oRNA design since June 2021, following a role as a Research Associate focused on high throughput oRNA production. Previous experience includes a research internship at the IBBR Institute for Bioscience and Biotechnology Research, where research involved computational methods for assessing the thermostability of mutated proteins and analyzing free energy shifts related to pyridoxine therapy. Rahul holds a degree from the University of Illinois Urbana-Champaign, completed in 2021, and graduated from Thomas Sprigg Wootton High School in 2017.
Orna Therapeutics
1 followers
Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics with the potential to change the way it treats disease. Orna’s proprietary platform combines novel technology to create oRNAs that drive protein expression with validated and unique delivery solutions.